Market Indices
Latest News
 |
| ||
| ||
| ||
|
Price Targets
from Industrial Alliance Securities issued a price target of $9.00 for SPIR on 2025-12-23 21:17:41.The adjusted price target was set to $9.00.At the time of the announcement,
December 23, 2025 SPIR -4.93%
from Oppenheimer issued a price target of $283.00 for SPRB on 2025-12-23 11:26:53.The adjusted price target was set to $283.00.At the time of the announcement, SPRB was...
December 23, 2025 SPRB 0.32%
from UBS issued a price target of $6.00 for EARN on 2025-12-23 09:45:53.The adjusted price target was set to $6.00.At the time of the announcement, EARN was...
December 23, 2025 EARN 0.86%
Daniil Gataulin from Chardan Capital issued a price target of $16.00 for ANNX on 2025-12-23 09:30:14.The adjusted price target was set to $16.00.At the time of the announcement,
December 23, 2025 ANNX 1.24%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| MAPSW WM Technology Inc | 0.01
115.00% | ||||||||||||||||||
| OMER Omeros Corporation | 15.41
76.06% | ||||||||||||||||||
| XOSWW Xos Equity Warrants | 0.01
32.61% | ||||||||||||||||||
| IZM ICZOOM Group Inc. | 2.28
26.67% | ||||||||||||||||||
| CDIOW Cardio Diagnostics Holdin | 0.03
20.00% | ||||||||||||||||||
| DAVEW Dave Inc. Warrants | 1.06
19.09% | ||||||||||||||||||
| TSE Trinseo PLC | 0.57
18.79% | ||||||||||||||||||
| RPTX Repare Therapeutics Inc. | 2.56
17.74% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP -1.58%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE 0.46%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK 0.78%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN -3.17%